Escitalopram CYP2C19 Poor Metabolizer Risk

Assess escitalopram QTc prolongation and adverse event risk in CYP2C19 poor metabolizers. AUC 3-fold higher requiring dose cap at 10mg/day.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How to Use

Enter the values for the scenario you are assessing. Assess escitalopram QTc prolongation and adverse event risk in CYP2C19 poor metabolizers. AUC 3-fold higher requiring dose cap at 10mg/day. Use the escitalopram cyp2c19 result to inform your calculation.

Related Calculators

Sertraline CYP2C19

Medical Ultra-depth

Frequently Asked Questions